Bruce & Co. Inc. lowered its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the period. Bruce & […]
Bruce & Co. Inc. trimmed its stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the quarter. Bruce & […]
Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Fate Therapeutics (NASDAQ:FATE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Volatility & Risk Sana Biotechnology has a […]
Brokerages Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $6.58 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Certain Pre-Funded Warrants of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. These Pre-Funded Warrants will be under lockup for 61 days starting from 19-MAR-2024 to.